Bile acylcarnitine profiles in pediatric liver disease do not interfere with the diagnosis of long-chain fatty acid oxidation defects

Medicine & Life Sciences

• acylcarnitine 100%
• Bile 70%
• Fatty Acids 60%
• Liver Diseases 59%
• Pediatrics 45%
• 3-Hydroxyacyl-CoA Dehydrogenase Deficiency 30%
• Trifunctional Protein Deficiency With Myopathy And Neuropathy 25%
• Hepatobiliary Elimination 17%
• Butyryl-CoA Dehydrogenase 12%
• Acyl-CoA Dehydrogenase 11%
• Liver 10%
• Volatile Fatty Acids 8%
• Syringes 7%
• Tandem Mass Spectrometry 7%
• Autopsy 5%
• Acids 5%
• Prospective Studies 4%
• Biopsy 4%
• Population 2%

Chemical Compounds

• Long-Chain Fatty Acid 87%
• Acyl-CoA 60%
• Disorder 60%
• Fatty Acid 38%
• Short-Chain Fatty Acid 32%
• Oxidation Reaction 31%
• Organic Acid 23%
• Marker 20%
• Tandem Mass Spectrometry 19%
• Metabolic 19%
• Pharmacological Metabolism 18%
• Plasma 14%
• Time 8%